Untimely Applause Was a Distraction; Comment on “Shanghai Rising: Health Improvements as Measured by Avoidable Mortality since 2000”

Document Type : Commentary


1 Department of Social Medicine, School of Public Health, Fudan University, Shanghai, China

2 Jiann-Ping Hsu College of Public Health, Georgia Southern University, Statesboro, GA, USA


The paper published in the January 2015 issue of this journal by Gusmano and colleagues entitled “Shanghai rising: health improvements as measured by avoidable mortality since 2000” has spurred this commentary. We discuss controversial issues surrounding the concept of avoidable mortality in health service research in general and Gusmano’s study in particular. The impact of overall social development on mortality may be underappreciated in Gusmano’s report; the innovative efforts of healthcare professionals to use cutting-edge technology and evidenceapproved preventive strategies to reduce healthcare cost and improve the life quality of community members may not necessarily come to fruition in death reduction, and might be undervalued, too. More critically, the shape and magnitude of emerging health issues in Shanghai, such as accidents and injuries, pollution-related cancers, may be camouflaged in Gusmano’s report. We conclude this commentary by suggesting the most urgent questions to be addressed in the future studies.


Main Subjects

  1. Gusmano MK, Rodwin VG, Wang C, Weisz D, Luo L, Hua F. Shanghai rising: health improvements as measured by avoidable mortality since 2000. Int J Health Policy Manag 2015; 4: 7-12. doi: 10.15171/ijhpm.2015.07
  2. Rutstein DD, Berenberg W, Chalmers TC, Child CG 3rd, Fishman AP, Perrin EB. Measuring the quality of medical care. A clinical method. N Engl J Med 1976; 294: 582-8. doi: 10.1056/nejm197603112941104
  3. Holland WW. European Community Atlas of Avoidable Death. Oxford: Oxford Medical Publications; 1988. Commission of the European Communities Health Services Research, No. 3.
  4. Mossialos E, Smith PC, Papanicolas I, Leatherman S. Performance measurement for health system improvement: Experiences, challenges and prospects.  New York: Cambridge University Press; 2009. The Cambridge Health Economics, Policy and Management series.
  5. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356: 2388-98.
  6. Nolte E, McKee CM. Measuring the health of nations: updating an earlier analysis. Health Aff (Millwood ) 2008; 27: 58-71. doi: 10.1377/hlthaff.27.1.58
  7. World Health Organization (WHO). The World Health Report 2000, Health Systems: Improving Performance.  Geneva: WHO; 2000.
  8. Omariba DW. Immigration, ethnicity, and avoidable mortality in Canada, 1991-2006. Ethn Health 2015; 1-28. doi: 10.1080/13557858.2014.995155
  9. Manderbacka K, Peltonen R, Martikainen P. Amenable mortality by household income and living arrangements: a linked register-based study of Finnish men and women in 2000-2007. J Epidemiol Community Health 2014; 68: 965-70. doi: 10.1136/jech-2014-204272
  10. Kunitz SJ, Veazie M, Henderson JA. Historical trends and regional differences in all-cause and amenable mortality among American Indians and Alaska Natives since 1950. Am J Public Health 2014; 104: S268-77. doi: 10.2105/ajph.2013.301684
  11. Nolasco A, Quesada JA, Moncho J, Melchor I, Pereyra-Zamora P, Tamayo-Fonseca N, et al. Trends in socioeconomic inequalities in amenable mortality in urban areas of Spanish cities, 1996-2007. BMC Public Health 2014; 14: 299. doi: 10.1186/1471-2458-14-299
  12. Omranikhoo H, Pourreza A, Ardebili HE, Heydari H, Forushani AR. Avoidable mortality differences between rural and urban residents during 2004-2011: a case study in Iran. Int J Health Policy Manag 2013; 1: 287-93. doi: 10.15171/ijhpm.2013.58
  13. Ringback WG, Gullberg A, Rosen M. Avoidable mortality among psychiatric patients. Soc Psychiatry Psychiatr Epidemiol 1998; 33: 430-7.
  14. Malcolm M. Avoidable mortality and life expectancy in New Zealand. J Epidemiol Community Health 1994; 48: 211. doi: 10.1136/jech.48.2.211
  15. Gaizauskiene A, Gurevicius R. Avoidable mortality in Lithuania. J Epidemiol Community Health 1995; 49: 281-4. doi: 10.1136/jech.49.3.281
  16. Rasanen S, Hakko H, Viilo K, Meyer-Rochow VB, Moring J. Avoidable mortality in long-stay psychiatric patients of Northern Finland. Nord J Psychiatry 2005; 59: 103-8. doi: 10.1136/jech.49.3.281
  17. Tobias M, Jackson G. Avoidable mortality in New Zealand, 1981-97. Aust N Z J Public Health 2001; 25: 12-20. doi: 10.1111/j.1467-842x.2001.tb00543.x
  18. Piers LS, Carson NJ, Brown K, Ansari Z. Avoidable mortality in Victoria between 1979 and 2001. Aust N Z J Public Health 2007; 31: 5-12. doi: 10.1111/j.1753-6405.2007.00002.x
  19. Holden G, Moncher MS, Gordon A, Schinke SP. Avoidable mortality risks and cultural identification among urban Native American youths. J Adolesc Health Care 1990; 11: 288. doi: 10.1016/0197-0070(90)90036-2
  20. Tang KK, Chin JT, Rao DS. Avoidable mortality risks and measurement of wellbeing and inequality. J Health Econ 2008; 27: 624-41. doi: 10.1016/j.jhealeco.2007.08.003
  21. Macinko J, Elo IT. Black-white differences in avoidable mortality in the USA, 1980-2005. J Epidemiol Community Health 2009; 63: 715-21. doi: 10.1136/jech.2008.081141
  22. Holland WW. Commentary: should we not go further than descriptions of avoidable mortality? Int J Epidemiol 2003; 32: 447-8. doi: 10.1093/ije/dyg157
  23. Andreev EM, Nolte E, Shkolnikov VM, Varavikova E, McKee M. The evolving pattern of avoidable mortality in Russia. Int J Epidemiol 2003; 32: 437-46.
  24. Alleyne G. Amenable mortality: a different view. Health Aff (Millwood) 2008; 27: 1196-7. doi: 10.1377/hlthaff.27.4.1196-a
  25. Allin S, Grignon M. Examining the role of amenable mortality as an indicator of health system effectiveness. Healthc Policy 2014; 9: 12-9. doi: 10.12927/hcpol.2014.23733
  26. Lavergne R, McGrail K. Amenable (or avoidable) mortality as an indicator of health system effectiveness. Healthc Policy 2014; 10: 8-9.
  27. Lavergne MR, McGrail K. What, if anything, does amenable mortality tell us about regional health system performance? Health Policy 2013; 8: 79-90. doi: 10.12927/hcpol.2013.23178
  28. Perez G, Rodriguez-Sanz M, Cirera E, Perez K, Puigpinos R, Borrell C. Commentary: approaches, strengths, and limitations of avoidable mortality. J Public Health Policy 2014; 35: 171-84. doi: 10.1057/jphp.2014.8
  29. Mackenbach JP1, Hoffmann R, Khoshaba B, Plug I, Rey G, Westerling R, et al. Using 'amenable mortality' as indicator of healthcare effectiveness in international comparisons: results of a validation study. J Epidemiol Community Health 2013; 67: 139-46. doi: 10.1136/jech-2012-201471
  30. Schoenbaum SC, Schoen C, Nicholson JL, Cantor JC. Mortality amenable to health care in the United States: the roles of demographics and health systems performance. J Public Health Policy 2011; 32: 407-29. doi: 10.1057/jphp.2011.42
  31. Shen X, Xia Z, Li X, Wu J, Wang L, Li J, et al. Tuberculosis in an urban area in China: differences between urban migrants and local residents. PLoS One 2012; 7: e51133. doi: 10.1371/journal.pone.0051133
  32. Salami AK, Oluboyo PO. Management outcome of pulmonary tuberculosis: a nine year review in Ilorin. West Afr J Med 2003; 22: 114-9. doi: 10.4314/wajm.v22i2.27928
  33. Yan F, Tang S, Zhang J. Global implications of China's healthcare reform. Int J Health Plann Manage 2014. doi: 10.1002/hpm.2252
  34. National Bureau of Statistics of China. Basic Statistics on Traffic Accidents by Region (2010).  China Statistical Yearbook; 2011.
  35. Wenjun C. Shanghai has nation's highest rate of cancer [internet]. Shanghai Daily. Jan 17, 2014. Available from: http://shanghaidaily.com/supplement/Shanghai-has-nation           s-highest-rate-of-cancer/shdaily.shtml
  36. Ren D. Surge in cancer deaths gives Shanghai residents pause. South China Morning Post China's News; May 4, 2013. Available from: http://www.scmp.com/news/china/article/1229479/            surge-cancer-deaths-gives-shanghai-residents-pause